| Robert J. Balazs | |
|---|---|
| Photo placeholder | |
| Affiliations | NIH NIMH |
| Country | USA |
| H-index | 40 |
| Research Focus | Alzheimer's Disease |
| Mechanisms | Neuropharmacology |
Robert J. Balazs is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Balazs has developed research programs that bridge basic neuroscience, translational biomarker work, and clinical interpretation. Across appointments at NIH and NIMH, their group has helped define how mechanistic discoveries are converted into robust disease models and clinically actionable hypotheses.
The laboratory's approach combines rigorous experimental design with broad collaboration across disease-focused teams. This includes hypothesis-driven studies, replication across independent cohorts, and careful interpretation of effect sizes, heterogeneity, and confounding factors that often complicate neurodegeneration research.
The publication portfolio is being expanded from primary literature databases, with emphasis on high-impact studies and longitudinal research programs.
Their program contributes to translational and mechanistic work in [Alzheimer's disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX--.
The lab emphasizes Neuropharmacology to connect molecular findings with patient outcomes.
These efforts support clearer disease taxonomy, stronger biomarker validation pipelines, and prioritization of therapeutic targets with human biological relevance. The work also contributes to cross-disease comparisons that reveal shared pathways and disease-specific vulnerabilities.
Current priorities in Balazs's research ecosystem include improving reproducibility across cohorts, integrating multi-omic and longitudinal clinical datasets, and clarifying which biological signals are most predictive of near-term progression and treatment response. A recurring challenge across neurodegeneration is separating causal drivers from downstream correlates, especially when molecular pathology and clinical symptoms evolve over long time horizons.
Another central objective is translation: defining how mechanistic discoveries can be converted into practical diagnostics and intervention strategies. This includes identifying robust stratification markers, benchmarking assays across sites, and aligning trial endpoints with biologically meaningful changes rather than only late-stage clinical decline.
Collaborator network pending enrichment.
[Balazs R. "Trophic effect of glutamate." Current topics in medicinal chemistry (2006). DOI)
[Tong L et al.. "Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical [neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX--." J Neurosci (2004). DOI)
[Jørgensen OS, Brooksbank BW, Balázs R. "Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer's Disease." Journal of the neurological sciences (1990). DOI90182-m)
[Ulas J et al.. "Expression of metabotropic glutamate receptor 5 is increased in [astrocytes[/entities/[astrocytes[/entities/[astrocytes[/entities/[astrocytes--TEMP--/entities)--FIX-- after kainate-induced epileptic seizures." Glia (2000). [PubMed]https://pubmed.ncbi.nlm.nih.gov/10797615/)
[Soiampornkul R et al.. "Interleukin-1beta interferes with signal transduction induced by neurotrophin-3 in cortical neurons." Brain research (2008). DOI)
[Balazs R. "Epigenetic mechanisms in Alzheimer's Disease." Degenerative neurological and neuromuscular disease (2014). DOI)
[Shen H et al.. "Physical activity elicits sustained activation of the cyclic AMP response element-binding protein and mitogen-activated protein kinase in the rat [hippocampus[/brain-regions/[hippocampus[/brain-regions/[hippocampus[/brain-regions/[hippocampus--TEMP--/brain-regions)--FIX--." Neuroscience (2001). DOI00315-3)
[Pike CJ, Balázs R, Cotman CW. "Attenuation of beta-amyloid neurotoxicity in vitro by potassium-induced depolarization." Journal of neurochemistry (1996). DOI)
[Balazs R. "Trophic effect of glutamate." Current topics in medicinal chemistry (2006). [DOI: 10.2174/156802606777323700]https://doi.org/10.2174/156802606777323700) PubMed: 16787270
[Tong L et al.. "Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons." J Neurosci (2004). [DOI: 10.1523/JNEUROSCI.5463-03.2004]https://doi.org/10.1523/JNEUROSCI.5463-03.2004) PubMed: 15282285
[Jørgensen OS, Brooksbank BW, Balázs R. "Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer's Disease." Journal of the neurological sciences (1990). [DOI: 10.1016/0022-510x(90)90182-m]https://doi.org/10.1016/0022-510x(90)90182-m) PubMed: 1977892
[Ulas J et al.. "Expression of metabotropic glutamate receptor 5 is increased in astrocytes after kainate-induced epileptic seizures." Glia (2000). [PubMed: 10797615]https://pubmed.ncbi.nlm.nih.gov/10797615/)
[Soiampornkul R et al.. "Interleukin-1beta interferes with signal transduction induced by neurotrophin-3 in cortical neurons." Brain research (2008). [DOI: 10.1016/j.brainres.2007.10.051]https://doi.org/10.1016/j.brainres.2007.10.051) PubMed: 18036576
[Balazs R. "Epigenetic mechanisms in Alzheimer's Disease." Degenerative neurological and neuromuscular disease (2014). [DOI: 10.2147/DNND.S37341]https://doi.org/10.2147/DNND.S37341) PubMed: 32669903
[Shen H et al.. "Physical activity elicits sustained activation of the cyclic AMP response element-binding protein and mitogen-activated protein kinase in the rat hippocampus." Neuroscience (2001). [DOI: 10.1016/s0306-4522(01)00315-3]https://doi.org/10.1016/s0306-4522(01)00315-3) PubMed: 11731096
[Pike CJ, Balázs R, Cotman CW. "Attenuation of beta-amyloid neurotoxicity in vitro by potassium-induced depolarization." Journal of neurochemistry (1996). [DOI: 10.1046/j.1471-4159.1996.67041774.x]https://doi.org/10.1046/j.1471-4159.1996.67041774.x) PubMed: 8858966
[Balazs R. "Trophic effect of glutamate." Current topics in medicinal chemistry (2006). DOI)
[Tong L et al.. "Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons." J Neurosci (2004). DOI)
[Jørgensen OS, Brooksbank BW, Balázs R. "Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer's Disease." Journal of the neurological sciences (1990). DOI90182-m)
[Ulas J et al.. "Expression of metabotropic glutamate receptor 5 is increased in astrocytes after kainate-induced epileptic seizures." Glia (2000). [PubMed]https://pubmed.ncbi.nlm.nih.gov/10797615/)
[Soiampornkul R et al.. "Interleukin-1beta interferes with signal transduction induced by neurotrophin-3 in cortical neurons." Brain research (2008). DOI)
[Balazs R. "Epigenetic mechanisms in Alzheimer's Disease." Degenerative neurological and neuromuscular disease (2014). DOI)
[Shen H et al.. "Physical activity elicits sustained activation of the cyclic AMP response element-binding protein and mitogen-activated protein kinase in the rat hippocampus." Neuroscience (2001). DOI00315-3)
[Pike CJ, Balázs R, Cotman CW. "Attenuation of beta-amyloid neurotoxicity in vitro by potassium-induced depolarization." Journal of neurochemistry (1996). DOI)
[Balazs R. "Trophic effect of glutamate." Current topics in medicinal chemistry (2006). [DOI: 10.2174/156802606777323700]https://doi.org/10.2174/156802606777323700) PubMed: 16787270
[Tong L et al.. "Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons." J Neurosci (2004). [DOI: 10.1523/JNEUROSCI.5463-03.2004]https://doi.org/10.1523/JNEUROSCI.5463-03.2004) PubMed: 15282285
[Jørgensen OS, Brooksbank BW, Balázs R. "Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer's Disease." Journal of the neurological sciences (1990). [DOI: 10.1016/0022-510x(90)90182-m]https://doi.org/10.1016/0022-510x(90)90182-m) PubMed: 1977892
[Ulas J et al.. "Expression of metabotropic glutamate receptor 5 is increased in astrocytes after kainate-induced epileptic seizures." Glia (2000). [PubMed: 10797615]https://pubmed.ncbi.nlm.nih.gov/10797615/)
[Soiampornkul R et al.. "Interleukin-1beta interferes with signal transduction induced by neurotrophin-3 in cortical neurons." Brain research (2008). [DOI: 10.1016/j.brainres.2007.10.051]https://doi.org/10.1016/j.brainres.2007.10.051) PubMed: 18036576
[Balazs R. "Epigenetic mechanisms in Alzheimer's Disease." Degenerative neurological and neuromuscular disease (2014). [DOI: 10.2147/DNND.S37341]https://doi.org/10.2147/DNND.S37341) PubMed: 32669903
[Shen H et al.. "Physical activity elicits sustained activation of the cyclic AMP response element-binding protein and mitogen-activated protein kinase in the rat hippocampus." Neuroscience (2001). [DOI: 10.1016/s0306-4522(01)00315-3]https://doi.org/10.1016/s0306-4522(01)00315-3) PubMed: 11731096
[Pike CJ, Balázs R, Cotman CW. "Attenuation of beta-amyloid neurotoxicity in vitro by potassium-induced depolarization." Journal of neurochemistry (1996). [DOI: 10.1046/j.1471-4159.1996.67041774.x]https://doi.org/10.1046/j.1471-4159.1996.67041774.x) PubMed: 8858966
[Balazs R. "Trophic effect of glutamate." Current topics in medicinal chemistry (2006). DOI)
[Tong L et al.. "Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons." J Neurosci (2004). DOI)
[Jørgensen OS, Brooksbank BW, Balázs R. "Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer's Disease." Journal of the neurological sciences (1990). DOI90182-m)
[Ulas J et al.. "Expression of metabotropic glutamate receptor 5 is increased in astrocytes after kainate-induced epileptic seizures." Glia (2000). [PubMed]https://pubmed.ncbi.nlm.nih.gov/10797615/)
[Soiampornkul R et al.. "Interleukin-1beta interferes with signal transduction induced by neurotrophin-3 in cortical neurons." Brain research (2008). DOI)
[Balazs R. "Epigenetic mechanisms in Alzheimer's Disease." Degenerative neurological and neuromuscular disease (2014). DOI)
[Shen H et al.. "Physical activity elicits sustained activation of the cyclic AMP response element-binding protein and mitogen-activated protein kinase in the rat hippocampus." Neuroscience (2001). DOI00315-3)
[Pike CJ, Balázs R, Cotman CW. "Attenuation of beta-amyloid neurotoxicity in vitro by potassium-induced depolarization." Journal of neurochemistry (1996). DOI)
[Balazs R. "Trophic effect of glutamate." Current topics in medicinal chemistry (2006). [DOI: 10.2174/156802606777323700]https://doi.org/10.2174/156802606777323700) PubMed: 16787270
[Tong L et al.. "Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons." J Neurosci (2004). [DOI: 10.1523/JNEUROSCI.5463-03.2004]https://doi.org/10.1523/JNEUROSCI.5463-03.2004) PubMed: 15282285
[Jørgensen OS, Brooksbank BW, Balázs R. "Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer's Disease." Journal of the neurological sciences (1990). [DOI: 10.1016/0022-510x(90)90182-m]https://doi.org/10.1016/0022-510x(90)90182-m) PubMed: 1977892
[Ulas J et al.. "Expression of metabotropic glutamate receptor 5 is increased in astrocytes after kainate-induced epileptic seizures." Glia (2000). [PubMed: 10797615]https://pubmed.ncbi.nlm.nih.gov/10797615/)
[Soiampornkul R et al.. "Interleukin-1beta interferes with signal transduction induced by neurotrophin-3 in cortical neurons." Brain research (2008). [DOI: 10.1016/j.brainres.2007.10.051]https://doi.org/10.1016/j.brainres.2007.10.051) PubMed: 18036576
[Balazs R. "Epigenetic mechanisms in Alzheimer's Disease." Degenerative neurological and neuromuscular disease (2014). [DOI: 10.2147/DNND.S37341]https://doi.org/10.2147/DNND.S37341) PubMed: 32669903
[Shen H et al.. "Physical activity elicits sustained activation of the cyclic AMP response element-binding protein and mitogen-activated protein kinase in the rat hippocampus." Neuroscience (2001). [DOI: 10.1016/s0306-4522(01)00315-3]https://doi.org/10.1016/s0306-4522(01)00315-3) PubMed: 11731096
[Pike CJ, Balázs R, Cotman CW. "Attenuation of beta-amyloid neurotoxicity in vitro by potassium-induced depolarization." Journal of neurochemistry (1996). [DOI: 10.1046/j.1471-4159.1996.67041774.x]https://doi.org/10.1046/j.1471-4159.1996.67041774.x) PubMed: 8858966
[Balazs R. "Trophic effect of glutamate." Current topics in medicinal chemistry (2006). DOI)
[Tong L et al.. "Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons." J Neurosci (2004). DOI)
[Jørgensen OS, Brooksbank BW, Balázs R. "Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer's Disease." Journal of the neurological sciences (1990). DOI90182-m)
[Ulas J et al.. "Expression of metabotropic glutamate receptor 5 is increased in astrocytes after kainate-induced epileptic seizures." Glia (2000). [PubMed]https://pubmed.ncbi.nlm.nih.gov/10797615/)
[Soiampornkul R et al.. "Interleukin-1beta interferes with signal transduction induced by neurotrophin-3 in cortical neurons." Brain research (2008). DOI)
[Balazs R. "Epigenetic mechanisms in Alzheimer's Disease." Degenerative neurological and neuromuscular disease (2014). DOI)
[Shen H et al.. "Physical activity elicits sustained activation of the cyclic AMP response element-binding protein and mitogen-activated protein kinase in the rat hippocampus." Neuroscience (2001). DOI00315-3)
[Pike CJ, Balázs R, Cotman CW. "Attenuation of beta-amyloid neurotoxicity in vitro by potassium-induced depolarization." Journal of neurochemistry (1996). DOI)
[Balazs R. "Trophic effect of glutamate." Current topics in medicinal chemistry (2006). [DOI: 10.2174/156802606777323700]https://doi.org/10.2174/156802606777323700) PubMed: 16787270
[Tong L et al.. "Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons." J Neurosci (2004). [DOI: 10.1523/JNEUROSCI.5463-03.2004]https://doi.org/10.1523/JNEUROSCI.5463-03.2004) PubMed: 15282285
[Jørgensen OS, Brooksbank BW, Balázs R. "Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer's Disease." Journal of the neurological sciences (1990). [DOI: 10.1016/0022-510x(90)90182-m]https://doi.org/10.1016/0022-510x(90)90182-m) PubMed: 1977892
[Ulas J et al.. "Expression of metabotropic glutamate receptor 5 is increased in astrocytes after kainate-induced epileptic seizures." Glia (2000). [PubMed: 10797615]https://pubmed.ncbi.nlm.nih.gov/10797615/)
[Soiampornkul R et al.. "Interleukin-1beta interferes with signal transduction induced by neurotrophin-3 in cortical neurons." Brain research (2008). [DOI: 10.1016/j.brainres.2007.10.051]https://doi.org/10.1016/j.brainres.2007.10.051) PubMed: 18036576
[Balazs R. "Epigenetic mechanisms in Alzheimer's Disease." Degenerative neurological and neuromuscular disease (2014). [DOI: 10.2147/DNND.S37341]https://doi.org/10.2147/DNND.S37341) PubMed: 32669903
[Shen H et al.. "Physical activity elicits sustained activation of the cyclic AMP response element-binding protein and mitogen-activated protein kinase in the rat hippocampus." Neuroscience (2001). [DOI: 10.1016/s0306-4522(01)00315-3]https://doi.org/10.1016/s0306-4522(01)00315-3) PubMed: 11731096
[Pike CJ, Balázs R, Cotman CW. "Attenuation of beta-amyloid neurotoxicity in vitro by potassium-induced depolarization." Journal of neurochemistry (1996). [DOI: 10.1046/j.1471-4159.1996.67041774.x]https://doi.org/10.1046/j.1471-4159.1996.67041774.x) PubMed: 8858966
Recent publications by [Robert Balazs[/researchers/[robert-balazs[/researchers/[robert-balazs[/researchers/[robert-balazs--TEMP--/researchers)--FIX-- focus on computational neuroscience, neural network modeling, and AI applications in brain research.
Page auto-generated from NeuroWiki researcher database. Last updated: 2026-03-01.
Page auto-generated from NeuroWiki researcher database. Last updated: 2026-03-01.
The study of Robert J. Balazs has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.